Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D3FEAT: Viekira Pak for HCV in PWID
NCT02498015Phase 4Completed
- Sponsor
- The Kirby Institute
- Start
- Aug 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Viekira Pak in chronic hepatitis C (CHC), sponsored by The Kirby Institute. Started Aug 2016; status: completed.
02
Drugs
Viekira Pak
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on NCT02498015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02498015.